Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for Obesity in the US
Chungsoo Kim, Joseph S. Ross, Ania M. Jastreboff, Daniella Meeker, Harry Freedman, Harlan M. Krumholz, Yuan Lu
Abstract
This study uses data from the US nationwide electronic health record–based Epic Cosmos Dataset to examine prescriptions for semaglutide and tirzepatide, focusing on differences across race, ethnicity, social vulnerability, and urbanicity and assess the need for strategies to promote equitable access to these therapies.
Topics & Concepts
MedicineEPICSemaglutideEthnic groupMedical prescriptionObesityVulnerability (computing)Race (biology)Environmental healthDemographyGerontologyFamily medicinePharmacologyDiabetes mellitusInternal medicineEndocrinologyLiraglutideBiologyComputer securityArtBotanyLiteratureType 2 diabetesAnthropologySociologyComputer scienceDiabetes Treatment and ManagementPharmaceutical Practices and Patient OutcomesPharmacology and Obesity Treatment